Case Studies

The following case studies provide a brief overview of several projects for which Fulcrum's clients have greatly benefited through our approach to drug development and regulatory services. If you would like to discuss case studies or our experience directly related to your projects please contact the business development team at Fulcrum.

Development to Phase I

An emerging pharmaceutical company was faced with a familiar dilemma when it discovered a novel anti-cancer agent that demonstrated strong activity in animal models... Read more >

Optimising Non-clinical Drug Development

Fulcrum's client, an innovative pharmaceutical company, specializes in the discovery and development of novel therapeutics. They achieve this not only by discovering their own molecules... Read More >

Clinical Study Program in Oncology

Investigator initiated trials are used to widen prescriber experience of a drug around the time of launch. New products may elicit numerous and frequent requests to allow the use of the agent in regimens or settings... Read More >

Compound Review

The client was looking to in-license an analgesic which had a wide non-clinical pharmacology data package and an investigator sponsored pilot study... Read more >

Supplier Selection & Management

Fulcrum's client was a global technology commercialisation company with diverse interests including a share of the intellectual property associated with a "big pharma" partner's biotechnology product... Read More >

Process Documentation

The client was looking to in-license an analgesic which had a wide non-clinical pharmacology data package and an investigator sponsored pilot study... Read more >



>> Back to top